Amneal’s Shares Slump On Slashed Earnings Outlook and Cost-Cutting Plan

11 Jul 2019

• By Aidan Fry

Investors have downgraded their valuation of Amneal after the US firm blamed a highly competitive local generics market for slashing its earnings forecast. To improve its competitiveness, Amneal is planning to cut 550 jobs and close two plants.

Cutting The Costs/ Inflation Comes Back - Image — Amneal is looking to cut operating costs as if faces intense competition in the US generics arena • Source: Shutterstock

Amneal’s Shares Slump On Slashed Earnings Outlook and Cost-Cutting Plan

More from Generics

More from Products